Working… Menu

Phase I Trial of PACE for Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03110588
Recruitment Status : Recruiting
First Posted : April 12, 2017
Last Update Posted : September 12, 2019
Astellas Pharma Inc
Information provided by (Responsible Party):
Mansoor Saleh, University of Alabama at Birmingham

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : August 1, 2023